Endoscopic Implantation of Enteryx for the Treatment of GERD

Completed · Not applicable

Conditions studied: Gastroesophageal Reflux

In brief

The study objective is to assess the long term safety and effectiveness of Enteryx device in commercial use. The long-term effects beyond one year of treatment with Enteryx have not been established.

Key facts

Study ID

NCT00346905

Run by

Beth Israel Deaconess Medical Center

People needed

16

Starts

2003-10-01

Expected to finish

2008-02-01

Last updated by the study team

2017-07-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• GERD responsive to and requiring daily PPI therapy

You may not qualify if…

• Esophageal varices, particularly related to portal hypertension • Patients whom the physician determines to be a poor candidate for endoscopic procedures and/or anesthesia.
• Patients must also be willing to allow their data to be shared with the Sponsor and FDA.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.